MedPath

toxic effect of creatine supplementatio

Not Applicable
Conditions
Drug or medicament, unspecified.
Drug or medicament, unspecified
Registration Number
IRCT201305124663N15
Lead Sponsor
niversity of Tabriz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
27
Inclusion Criteria

Inclusion:male; 18-26 years old; healthy; wrestling athletes;BMI<12; at least 3 years of professional wrestling experience; without any creatine consumption( during 3 months prior to the stud) Exclusion: Diseases; Injuries; Uncontrolled intake of creatine supplements during the period

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rinary formaldehyde. Timepoint: 24 hour before and after the Cr loading phase. Method of measurement: Gas chromatography–mass spectrometry (GC-MS).;Ceartine kinase (CK). Timepoint: 24 hour before and after supplementation protocol. Method of measurement: photometric methods with commercial kits (Bionik kit).;Lactate Dehydrogenase(LDH). Timepoint: 24 hour before and after supplementation protocol. Method of measurement: photometric methods with commercial kits (Bionik kit).;Alanine aminotransferase (ALT). Timepoint: 24 hour before and after supplementation protocol. Method of measurement: photometric methods with commercial kits (Bionik kit).;Aspartate aminotransferase (AST). Timepoint: 24 hour before and after supplementation protocol. Method of measurement: photometric methods with commercial kits (Bionik kit).
Secondary Outcome Measures
NameTimeMethod
Blood Pressure. Timepoint: 30 minutes before and after firs and last trainig session. Method of measurement: Aneroid blood pressure measurement.
© Copyright 2025. All Rights Reserved by MedPath